LACY GONZALEZ: Open Payments
NPI 1841628443 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,642 in 136 payments from 20 companies in 2025. Trend: 2023 $3,454 · 2024 $4,868 · 2025 $2,642
Food & beverage: $2,642
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 27 | $375 |
| REVANCE THERAPEUTICS, INC. | 4 | $281 |
| Regeneron Healthcare Solutions, Inc. | 10 | $261 |
| UCB, Inc. | 9 | $243 |
| ABBVIE INC. | 19 | $236 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $166 |
| PFIZER INC. | 10 | $160 |
| GENZYME CORPORATION | 5 | $149 |
| Incyte Corporation | 7 | $148 |
| Arcutis Biotherapeutics, Inc. | 7 | $138 |
Products named: DUPIXENT, DAXXIFY, Bimzelx, COSENTYX, RINVOQ, OPZELURA, CIBINQO, ILUMYA.
Industry payments across TX — which companies pay providers there.
